L-MARC Rsrch CenterLouisville, Kentucky, United States
Disclosure information not submitted.
MON-727 - Participant-Reported Weight Reduction and Reasons for Continuing or Discontinuing Tirzepatide Treatment: Insights from the PERCEPTIONS Longitudinal Survey at 3 Months
Monday, June 15, 20269:00 AM - 2:00 PM CT
MON-728 - Patient-reported improvements in appetite control, quality of life, and work-related outcomes following tirzepatide treatment for obesity or overweight in the US: Results from 3-month PERCEPTIONS survey
.jpg)
.jpg)